Skip to main content

Save up to 20% on Elsevier print and eBooks with free shipping. No promo code needed.

Save up to 20% on print and eBooks.

Clinical Application of Repurposed Drugs

1st Edition, Volume 207 - September 1, 2024

Editor: Vijai Singh

Language: English
Hardback ISBN:
9 7 8 - 0 - 4 4 3 - 2 4 1 1 4 - 7
eBook ISBN:
9 7 8 - 0 - 4 4 3 - 2 4 1 1 5 - 4

Clinical applications of repurposed drug represents drug discovery and development which is a tedious process that requires 10-15 years of time, investments up to $1-2 billion, an… Read more

Clinical Application of Repurposed Drugs

Purchase options

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Institutional subscription on ScienceDirect

Request a sales quote

Clinical applications of repurposed drug represents drug discovery and development which is a tedious process that requires 10-15 years of time, investments up to $1-2 billion, and have high risk of failure to enter into market for clinical applications. As the drugs has to pass through number of developmental phase, the likelihood for a drug to be approved from phase I clinical trial to United States of Food and Drug Administration (USFDA) approval is less than 10%. More than 90% of drugs failed in due to toxicity, efficacy and clinical trials. Drug repurposing is one of the roadway to accelerating drug discovery and development for treating disease and thus to providing better quality of life. This volume Offers drug repurposing for viral, bacterial, fungal, protozoan infections, anxiety, depression, cancer, MASLD and MASH-cirrhosis, respiratory, rare disease, neurological disorders, metabolic disorders, regenerative disease and personalized medicine. This volume offers different aspects of the drug repurposing that can help the basic understanding of students, researchers, clinicians, entrepreneurs, and stakeholders to perform their research with great interest.